A detailed history of Beacon Investment Advisory Services, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 33,985 shares of EXAS stock, worth $1.95 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
33,985
Previous 42,901 20.78%
Holding current value
$1.95 Million
Previous $1.81 Million 27.7%
% of portfolio
0.1%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $378,305 - $631,520
-8,916 Reduced 20.78%
33,985 $2.31 Million
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $521,543 - $937,086
-12,619 Reduced 22.73%
42,901 $1.81 Million
Q1 2024

May 09, 2024

SELL
$56.27 - $73.77 $411,333 - $539,258
-7,310 Reduced 11.63%
55,520 $3.83 Million
Q4 2023

Feb 12, 2024

SELL
$59.06 - $75.72 $107,252 - $137,507
-1,816 Reduced 2.81%
62,830 $4.65 Million
Q3 2023

Oct 31, 2023

SELL
$65.94 - $99.04 $105,701 - $158,761
-1,603 Reduced 2.42%
64,646 $4.41 Million
Q2 2023

Jul 21, 2023

SELL
$62.68 - $95.05 $40,052 - $60,736
-639 Reduced 0.96%
66,249 $6.22 Million
Q1 2023

May 04, 2023

SELL
$47.19 - $70.77 $271,153 - $406,644
-5,746 Reduced 7.91%
66,888 $4.54 Million
Q4 2022

Jan 13, 2023

SELL
$30.35 - $53.15 $1.4 Million - $2.45 Million
-46,008 Reduced 38.78%
72,634 $0
Q3 2022

Oct 20, 2022

SELL
$31.97 - $49.37 $107,642 - $166,228
-3,367 Reduced 2.76%
118,642 $3.86 Million
Q2 2022

Jul 21, 2022

BUY
$35.61 - $76.23 $890 - $1,905
25 Added 0.02%
122,009 $4.81 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $50,537 - $72,470
878 Added 0.72%
121,984 $8.53 Million
Q4 2021

Feb 04, 2022

SELL
$72.5 - $100.68 $135,720 - $188,472
-1,872 Reduced 1.52%
121,106 $9.43 Million
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $352,657 - $484,787
-3,908 Reduced 3.08%
122,978 $11.7 Million
Q2 2021

Aug 02, 2021

BUY
$93.66 - $139.27 $83,919 - $124,785
896 Added 0.71%
126,886 $15.8 Million
Q1 2021

May 21, 2021

SELL
$116.57 - $155.01 $217,519 - $289,248
-1,866 Reduced 1.46%
125,990 $16.6 Million
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $189,757 - $270,738
-1,905 Reduced 1.47%
127,856 $16.9 Million
Q3 2020

Oct 29, 2020

BUY
$72.92 - $102.01 $347,682 - $486,383
4,768 Added 3.81%
129,761 $13.2 Million
Q2 2020

Jul 28, 2020

BUY
$55.75 - $92.75 $143,221 - $238,274
2,569 Added 2.1%
124,993 $10.9 Million
Q1 2020

May 05, 2020

SELL
$37.9 - $104.44 $104,983 - $289,298
-2,770 Reduced 2.21%
122,424 $7.1 Million
Q4 2019

Jan 31, 2020

BUY
$77.66 - $99.74 $9.72 Million - $12.5 Million
125,194 New
125,194 $11.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Beacon Investment Advisory Services, Inc. Portfolio

Follow Beacon Investment Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.